article thumbnail

Orion Corporation and Newel Health enter into licensing agreement for a digital therapeutic (DTx) ODD-403 (“Rohkea”) in pain

Digital Health Global

As showcased in the ‘ VIRPI ‘ study, ODD-403 marks a statistically significant advancement in chronic pain management. The core therapy areas of our pharmaceutical R&D are oncology and pain. The study revealed a notable reduction in the Tampa Scale for Kinesiophobia scores (-4.7

article thumbnail

Third Culture Capital Leads Latest Funding Round for Ciba Health

Digital Health Global

a chronic pain management and virtual care company, where he directed partnerships, clinical trials, regulatory submissions, hiring and expansion across North America. 31, 2022 at an undisclosed amount. Prior to Ciba Health, Clement co-founded Kaia Health Inc., The funding round led by 3CC closed on Dec.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Average Multiples and Key Drivers of Digital Therapeutics (DTx) M&A deals in 2023

Lloyd Price

These multiples are down from the levels seen in 2022, but they are still higher than the average EV to sales multiple for all industries. Diabetes management: DTx products can assist in blood glucose control, insulin therapy management, and lifestyle modification for diabetes patients. EV to EBITDA: 12.5x

article thumbnail

2023 Preview of Telemental Health Laws & Behavioral Telehealth Regulations

Telebehavioral Health Institute

After continuing COVID-related telemental health laws and behavioral telehealth regulations in 2022, many key issues for 2023 are already decided. Five new permanent telehealth codes have been approved for prolonged E/M services and chronic pain management.